Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-day vs five-day oral prednisolone for acute exacerbation in chronic obstructive pulmonary disease
TCTR20200327002Phase 3Enrolling by invitation
- Sponsor
- Khon Kaen Hospital
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in chronic obstructive pulmonary disease (COPD), sponsored by Khon Kaen Hospital. Started Feb 2020; status: enrolling by invitation.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20200327002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200327002.